The Beauty Health Company Reports Record Third Quarter 2021 Financial Results

Go back to The Beauty Health Company Reports Record Third Quarter 2021 Financial Results

The Beauty Health Company (SKIN) PT Raised to $32 at DA Davidson

November 10, 2021 8:51 AM EST

DA Davidson analyst Linda Bolton Weiser raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $32.00 (from $26.00) while maintaining a Buy rating.

The analyst commented, "SKIN reported a 3Q21 upside surprise, with sales beating consensus by 17% and EBITDA of $5.8M... More

The Beauty Health Company (SKIN) Reports Q3 Revenue of $68.1M

November 9, 2021 4:25 PM EST

The Beauty Health Company (NASDAQ: SKIN) reported Q3 EPS of ($1.63), versus ($0.06) reported last year. Revenue for the quarter came in at $68.1 million, versus $34.6 million reported last year.

GUIDANCE:

The Beauty Health Company sees FY2021 revenue of $245-255 billion.

For... More